How Does The MFDS Evaluate Pharmacovigilance Data?

The MFDS evaluates pharmacovigilance data by assessing adverse event reports, periodic safety update reports (PSURs), and risk management plans (RMPs). They analyze the benefit-risk profile, monitor drug safety trends, and may request additional safety studies. This process helps ensure ongoing drug safety and prompt action if new risks emerge.

Leave a Reply

You must be logged in to post a comment.